{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:12Z","timestamp":1707524892030},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"DOI":"10.7759\/cureus.34157","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T18:53:38Z","timestamp":1674586418000},"source":"Crossref","is-referenced-by-count":1,"title":["A Therapeutic Approach to Primary Hyperparathyroidism: A Collaborative Evaluation Between Endocrinology and Surgery"],"prefix":"10.7759","author":[{"given":"Andrew J","family":"Behnke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R","family":"Tershak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William  F","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adegbenga A","family":"Bankole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope O","year":"1966","unstructured":"Cope O. The study of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med. 1966, 274:1174-82. 10.1056\/NEJM196605262742105","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic","volume":"102","author":"Albright F","year":"1934","unstructured":"Albright F, Aub JC, Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA. 1934, 102:1276-87. 10.1001\/jama.1934.02750160010003","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker MD","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018, 14:115-25. 10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4158\/EP11206.OR","article-title":"Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism","volume":"18","author":"Morris GS","year":"2012","unstructured":"Morris GS, Landry CL, Grubbs EG, Jimenez C, Busaidy NL, Perrier ND. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocr Pract. 2012, 18:450-5. 10.4158\/EP11206.OR","journal-title":"Endocr Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-7-593","article-title":"NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement","volume":"114","year":"1991","unstructured":"NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism. consensus development conference statement. Ann Intern Med. 1991, 114:593-7. 10.7326\/0003-4819-114-7-593","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press DM","year":"2013","unstructured":"Press DM, Siperstein AE, Berber E, et al.. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013, 154:1232-7; discussion 1237-8. 10.1016\/j.surg.2013.06.051","journal-title":"Surgery"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002370","article-title":"Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure","volume":"266","author":"Balentine CJ","year":"2017","unstructured":"Balentine CJ, Xie R, Kirklin JK, Chen H. Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure. Ann Surg. 2017, 266:632-40. 10.1097\/SLA.0000000000002370","journal-title":"Ann Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31824dad7d","article-title":"Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?","volume":"255","author":"Yeh MW","year":"2012","unstructured":"Yeh MW, Wiseman JE, Ituarte PH, et al.. Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?. Ann Surg. 2012, 255:1179-83. 10.1097\/SLA.0b013e31824dad7d","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0424","article-title":"Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: opportunities for intervention at the patient and physician level to increase surgical referral","volume":"24","author":"Asban A","year":"2019","unstructured":"Asban A, Dombrowsky A, Mallick R, et al.. Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: opportunities for intervention at the patient and physician level to increase surgical referral. Oncologist. 2019, 24:e828-34. 10.1634\/theoncologist.2018-0424","journal-title":"Oncologist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers RA","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006, 21:171-7. 10.1359\/JBMR.050910","journal-title":"J Bone Miner Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian JP","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009, 94:335-9. 10.1210\/jc.2008-1763","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.2684","article-title":"An electronic medical record-based decision support tool for the diagnosis of primary hyperparathyroidism","volume":"182","author":"Dawood NB","year":"2022","unstructured":"Dawood NB, Shu ML, Tseng CH, Kim J, Nguyen DT, Leung AM, Yeh MW. An electronic medical record-based decision support tool for the diagnosis of primary hyperparathyroidism. JAMA Intern Med. 2022, 182:1000-2. 10.1001\/jamainternmed.2022.2684","journal-title":"JAMA Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.12.028","article-title":"Outpatient management of primary hyperparathyroidism","volume":"124","author":"Padmanabhan H","year":"2011","unstructured":"Padmanabhan H. Outpatient management of primary hyperparathyroidism. Am J Med. 2011, 124:911-4. 10.1016\/j.amjmed.2010.12.028","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.09.011","article-title":"The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?","volume":"150","author":"Wallace LB","year":"2011","unstructured":"Wallace LB, Parikh RT, Ross LV, et al.. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?. Surgery. 2011, 150:1102-12. 10.1016\/j.surg.2011.09.011","journal-title":"Surgery"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq261","article-title":"The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study","volume":"104","author":"Yu N","year":"2011","unstructured":"Yu N, Leese GP, Smith D, Donnan PT. The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM. 2011, 104:513-21. 10.1093\/qjmed\/hcq261","journal-title":"QJM"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128135-a-therapeutic-approach-to-primary-hyperparathyroidism-a-collaborative-evaluation-between-endocrinology-and-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:03Z","timestamp":1707508683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128135-a-therapeutic-approach-to-primary-hyperparathyroidism-a-collaborative-evaluation-between-endocrinology-and-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.34157","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}